Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation

Nature Genetics

Volumn 37, Issue 9, 2005, Pages 945-952

  Li, Xiaofeng ^a   Liu, Peng ^a   Liu, Wenzhong ^a   Maye, Peter ^a   Zhang, Jianghong ^b   Zhang, Yazhou ^a   Hurley, Marja ^a   Guo, Caiying ^a   Boskey, Adele ^c   Sun, Le ^d   Harris, Stephen E ^e   Rowe, David W ^a   Hua, Zhu Ke ^f   Wu, Dianqing ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c HOSPITAL FOR SPECIAL SURGERY   (United States)

^d Welson Pharmaceuticals   (China)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^f PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WNT PROTEIN; CARRIER PROTEIN; DKK2 PROTEIN, MOUSE; GLYCOPROTEIN; MUSCLE PROTEIN; MYOZ3 PROTEIN, HUMAN; MYOZ3 PROTEIN, MOUSE; ONCOPROTEIN; PROTEIN; SIGNAL PEPTIDE; WNT7B PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; CELL CULTURE; CELL DIFFERENTIATION; GENETICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOID; OSTEOPENIA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CELL INCLUSION; CYTOLOGY; FEMALE; MALE; METABOLISM; MOUSE MUTANT; NON-PROGRAMMATIC; PHYSIOLOGY;

ANIMALIA;

NON-PROGRAMMATIC;

ANIMALS; CALCIFICATION, PHYSIOLOGIC; CARRIER PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; GLYCOPROTEINS; INCLUSION BODIES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, KNOCKOUT; MUSCLE PROTEINS; OSTEOBLASTS; OSTEOGENESIS; PROTEINS; PROTO-ONCOGENE PROTEINS; WNT PROTEINS;

EID: 25144448701     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng1614     Document Type: Article

References (49)

1. NIH Consensus Conference Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. J. Am. Med. Assoc. 285, 785-795 (2001).
2. Kannus, P., Palvanen, M., Niemi, S., Parkkari, J. & Jarvinen, M. Epidemiology of osteoporotic pelvic fractures in elderly people in Finland: sharp increase in 1970-1997 and alarming projections for the new millennium. Osteoporos. Int. 11, 443-448 (2000).
3. Lips, P. Epidemiology and predictors of fractures associated with osteoporosis. Am. J. Med. 103, 3S-8S (1997).
4. Zuckerman, J.D. Hip fracture. N. Engl. J. Med. 334, 1519-1525 (1996).
5. Heaney, R.P. et al. Peak bone mass. Osteoporos. Int. 11, 985-1009 (2000).
6. Gong, Y. et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107, 513-523 (2001).
7. Little, R.D. et al. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am. J. Hum. Genet. 70, 11-19 (2002).
8. Boyden, L.M. et al. High bone density due to a mutation in LDL-receptor-related protein 5. N. Engl. J. Med. 346, 1513-1521 (2002).
9. Van Wesenbeeck, L. et al. Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. Am. J. Hum. Genet. 72, 763-771 (2003).
10. Kato, M. et al. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J. Cell Biol. 157, 303-314 (2002).
11. Babij, P. et al. High bone mass in mice expressing a mutant LRP5 gene. J. Bone Miner. Res. 18, 960-974 (2003).
12. Bodine, P.V. et al. The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol. Endocrinol. 18, 1222-1237 (2004).
13. Moon, R.T. & Kimelman, D. From cortical rotation to organizer gene expression: toward a molecular explanation of axis specification in Xenopus. Bioessays 20, 536-545 (1998).
14. Peifer, M. & Polakis, P. Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus. Science 287, 1606-1609 (2000).
15. Wodarz, A. & Nusse, R. Mechanisms of Wnt signaling in development. Annu. Rev. Cell Dev. Biol. 14, 59-88 (1998).
16. Bienz, M. & Clevers, H. Linking colorectal cancer to Wnt signaling. Cell 103, 311-320 (2000).
17. Barker, N. & Clevers, H. Catenins, Wnt signaling and cancer. Bioessays 22, 961-965 (2000).
18. He, X., Semenov, M., Tamai, K. & Zeng, X. LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development 131, 1663-1677 (2004).
19. Pandur, P. & Kuhl, M. An arrow for wingless to take-off. Bioessays 23, 207-210 (2001).
20. Nusse, R. Developmental biology. Making head or tail of Dickkopf. Nature 411, 255-256 (2001).
21. Mao, J. et al. Low-density lipoprotein receptor-related protein-5 binds to axin and regulates the canonical wnt signaling pathway. Mol. Cell 7, 801-809 (2001).
22. Tolwinski, N.S. et al. Wg/Wnt signal can be transmitted through arrow/LRP5,6 and Axin independently of Zw3/Gsk3beta activity. Dev. Cell 4, 407-418 (2003).
23. Wong, H.C. et al. Direct binding of the PDZ domain of Dishevelled to a conserved internal sequence in the C-terminal region of Frizzled. Mol. Cell 12, 1251-1260 (2003).
24. Gumbiner, B.M. Propagation and localization of Wnt signaling. Curr. Opin. Genet. Dev. 8, 430-435 (1998).
25. Dale, T.C. Signal transduction by the Wnt family of ligands. Biochem. J. 329, 209-223 (1998).
26. Li, X. et al. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J. Biol. Chem. 280, 19883-19887 (2005).
27. Glinka, A. et al. Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature 391, 357-362 (1998).
28. Monaghan, A.P. et al. Dickkopf genes are co-ordinately expressed in mesodermal lineages. Mech. Dev. 87, 45-56 (1999).
29. Krupnik, V.E. et al. Functional and structural diversity of the human Dickkopf gene family. Gene 238, 301-313 (1999).
30. Mao, B. et al. LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 411, 321-325 (2001).
31. Semenov, M.V. et al. Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr. Biol. 11, 951-961 (2001).
32. Bafico, A., Liu, G., Yaniv, A., Gazit, A. & Aaronson, S.A. Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nat. Cell Biol. 3, 683-686 (2001).
33. Mao, B. et al. Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. Nature 417, 664-667 (2002).
34. Li, L., Mao, J., Sun, L., Liu, W. & Wu, D. Second cysteine-rich domain of Dickkopf-2 activates canonical Wnt signaling pathway via LRP-6 independently of dishevelled. J. Biol. Chem. 277, 5977-5981 (2002).
35. Brott, B.K. & Sokol, S.Y. Regulation of Wnt/LRP signaling by distinct domains of Dickkopf proteins. Mol. Cell. Biol. 22, 6100-6110 (2002).
36. Li, L. et al. Dishevelled proteins lead to two different signaling pathways; regulation of the JNK and b-catenin pathways. J. Biol. Chem. 274, 129-134 (1999).
37. Li, L. et al. Axin and Frat-1 interact with Dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1. EMBO J. 18, 4233-4240 (1999).
38. Hsu, S.C., Galceran, J. & Grosschedl, R. Modulation of transcriptional regulation by Lef-1 in response to Wnt-1 signaling and association with beta-catenin. Mol. Cell. Biol. 18, 4807-4818 (1998).
39. Kalajzic, I. et al. Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage. J. Bone Miner. Res. 17, 15-25 (2002).
40. Zhang, Y. et al. The LRP5 high-bone-mass G171V mutation disrupts LRP5 interaction with Mesd. Mol. Cell. Biol. 24, 4677-4684 (2004).
41. Pandur, P., Lasche, M., Eisenberg, L.M. & Kuhl, M. Wnt-11 activation of a non-canonical Wnt signalling pathway is required for cardiogenesis. Nature 418, 636-641 (2002).
42. Wu, W., Glinka, A., Delius, H. & Niehrs, C. Mutual antagonism between dickkopf1 and dickkopf2 regulates Wnt/beta-catenin signalling. Curr. Biol. 10, 1611-1614 (2000).
43. Glass, D.A. II et al. Canonical wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev. Cell 8, 751-764 (2005).
44. Mukhopadhyay, M. et al. Dickkopf1 is required for embryonic head induction and limb morphogenesis in the mouse. Dev. Cell 1, 423-434 (2001).
45. Gregory, C.A., Singh, H., Perry, A.S. & Prockop, D.J. The Wnt signaling inhibitor Dkk-1 is required for re-entry into the cell cycle of human adult stem cells from bone marrow (hMSCs). J. Biol. Chem. 278, 28067-28078 (2003).
46. Ke, H.Z. et al. Deletion of the P2X7 nucleotide receptor reveals its regulatory roles in bone formation and resorption. Mol. Endocrinol. 17, 1356-1367 (2003).
47. Jee, W.S.S. et al. Histomorphometric assay of the growing long bone. in Handbook of Bone Morphology (ed. Takahashi, N.) 87-112 (Nishimusa, Niigata City, 1997).
48. Pfaffl, M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45 (2001).
49. Dimai, H.P. et al. Alkaline phosphatase levels and osteoprogenitor cell numbers suggest bone formation may contribute to peak bone density differences between two inbred strains of mice. Bone 22, 211-216 (1998).